Compare FA & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FA | HTFL |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2021 | N/A |
| Metric | FA | HTFL |
|---|---|---|
| Price | $15.84 | $28.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $15.67 | ★ $38.20 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.97 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,574,389,000.00 | N/A |
| Revenue This Year | $8.42 | $27.66 |
| Revenue Next Year | $7.26 | $23.55 |
| P/E Ratio | $1,577.00 | ★ N/A |
| Revenue Growth | ★ 83.02 | N/A |
| 52 Week Low | $8.82 | $20.13 |
| 52 Week High | $19.01 | $41.22 |
| Indicator | FA | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 47.72 |
| Support Level | $15.63 | $28.60 |
| Resistance Level | $16.19 | $28.98 |
| Average True Range (ATR) | 0.69 | 2.18 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 52.72 | 50.70 |
First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.